185 related articles for article (PubMed ID: 38422175)
1. Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
Curaj A; Vanholder R; Loscalzo J; Quach K; Wu Z; Jankowski V; Jankowski J
Circ Res; 2024 Mar; 134(5):592-613. PubMed ID: 38422175
[TBL] [Abstract][Full Text] [Related]
2. Heart-kidney crosstalk and role of humoral signaling in critical illness.
Virzì G; Day S; de Cal M; Vescovo G; Ronco C
Crit Care; 2014 Jan; 18(1):201. PubMed ID: 24393300
[TBL] [Abstract][Full Text] [Related]
3. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
[TBL] [Abstract][Full Text] [Related]
4. Cellular apoptosis in the cardiorenal axis.
Virzì GM; Clementi A; Ronco C
Heart Fail Rev; 2016 Mar; 21(2):177-89. PubMed ID: 26852141
[TBL] [Abstract][Full Text] [Related]
5. Significance of Kidney Disease in Cardiovascular Disease Patients.
Mehta A; Chandiramani R; Spirito A; Vogel B; Mehran R
Interv Cardiol Clin; 2023 Oct; 12(4):453-467. PubMed ID: 37673491
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Remodeling in Chronic Kidney Disease.
Kaesler N; Babler A; Floege J; Kramann R
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32150864
[TBL] [Abstract][Full Text] [Related]
7. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
Rapp N; Evenepoel P; Stenvinkel P; Schurgers L
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628
[TBL] [Abstract][Full Text] [Related]
8. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins.
Lekawanvijit S; Kompa AR; Wang BH; Kelly DJ; Krum H
Circ Res; 2012 Nov; 111(11):1470-83. PubMed ID: 23139286
[TBL] [Abstract][Full Text] [Related]
9. Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction.
Terker AS; Sasaki K; Arroyo JP; Niu A; Wang S; Fan X; Zhang Y; Nwosisi S; Zhang MZ; Harris RC
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F569-F577. PubMed ID: 33522414
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal Syndrome Revisited.
Zannad F; Rossignol P
Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
[TBL] [Abstract][Full Text] [Related]
11. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
Ronco C; Cicoira M; McCullough PA
J Am Coll Cardiol; 2012 Sep; 60(12):1031-42. PubMed ID: 22840531
[TBL] [Abstract][Full Text] [Related]
12. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
[TBL] [Abstract][Full Text] [Related]
13. Uremic Toxin-Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome.
Taguchi K; Elias BC; Brooks CR; Ueda S; Fukami K
Circ J; 2019 Dec; 84(1):2-8. PubMed ID: 31827008
[TBL] [Abstract][Full Text] [Related]
14. [Vascular dysfunction in Cardiorenal Syndrome type 4].
Sessa C; Granata A; Gaudio A; Xourafa A; Malatino L; Lentini P; Fatuzzo P; Rapisarda F; Castellino P; Zanoli L
G Ital Nefrol; 2020 Feb; 37(1):. PubMed ID: 32068357
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy.
Savira F; Magaye R; Hua Y; Liew D; Kaye D; Marwick T; Wang BH
Toxicol Lett; 2019 Jun; 308():34-49. PubMed ID: 30872129
[TBL] [Abstract][Full Text] [Related]
16. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
Fu Q; Cao L; Li H; Wang B; Li Z
Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
[TBL] [Abstract][Full Text] [Related]
17. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
[TBL] [Abstract][Full Text] [Related]
18. The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection.
Saito Y
J Mol Cell Cardiol; 2021 Feb; 151():106-112. PubMed ID: 33045252
[TBL] [Abstract][Full Text] [Related]
19. Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.
Napoli C; Casamassimi A; Crudele V; Infante T; Abbondanza C
Future Cardiol; 2011 Jul; 7(4):485-97. PubMed ID: 21797745
[TBL] [Abstract][Full Text] [Related]
20. Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome.
Lekawanvijit S; Kompa AR; Krum H
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F52-62. PubMed ID: 27147674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
